ResearcherNational University of SingaporeActive in the last 2 years
Manoj Garg
Matched on ORCID iD 0000-0002-3492-2957; OpenAlex author ID A5000444064, A5126386725. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 6
- SNHG10 promotes tumorigenesis through the EGFR/AKT/ERK/mTOR and miR-150-5p/VEGF-A axis, along with gemcitabine resistance in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41420-026-03040-y↗
- Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT sig… Last author DOI 10.1016/j.lfs.2024.123364↗
- Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade. Last author DOI 10.1007/s00018-022-04392-1↗
- The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic p… Last author DOI 10.1016/j.bbcan.2020.188423↗
- Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib. Co-author DOI 10.7150/jca.25138↗
- Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.2051↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gouri Pandya · 3 shared papers, 2020–2026 · strength 0.66
- Paper SNHG10 promotes tumorigenesis through the EGFR/AKT/ERK/mTOR and miR-150-5p/VEGF-A axis, along with gemcitabine resistan… DOI 10.1038/s41420-026-03040-y↗
- Paper Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modul… DOI 10.1016/j.lfs.2024.123364↗
- Paper The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenoca… DOI 10.1016/j.bbcan.2020.188423↗
- Anuradha Kirtonia · 3 shared papers, 2020–2025 · strength 0.56
- Paper Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modul… DOI 10.1016/j.lfs.2024.123364↗
- Paper Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/… DOI 10.1007/s00018-022-04392-1↗
- Paper The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenoca… DOI 10.1016/j.bbcan.2020.188423↗
- Rajender K. Motiani · 1 shared paper, 2026 · strength 0.26
- Harold Phillip Koeffler · 3 shared papers, 2014–2022 · strength 0.26
- Paper Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/… DOI 10.1007/s00018-022-04392-1↗
- Paper Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib. DOI 10.7150/jca.25138↗
- Paper Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. DOI 10.18632/oncotarget.2051↗
- David W. Dawson · 1 shared paper, 2022 · strength 0.16
- Wenwen Chien · 2 shared papers, 2014–2018 · strength 0.10
- Yun Zheng · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.